Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (23.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office |
| 03.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office |
| 02.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office |
| 22.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | f Operating Officer. Pursuant to Instruction 2 to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A is being file |
| 27.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certa |
| 13.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office |
Stammdaten
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Unternehmen & Branche
| Name | AETHLON MEDICAL INC |
|---|---|
| Ticker | AEMD |
| CIK | 0000882291 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 00808Y208 |
|---|---|
| ISIN | US00808Y2081 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,7 Mio. USD |
| Beta | 1,52 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | -2,018,245 | -2.45 | 8,057,128 | 6,713,097 | |
| 2025-09-30 | 10-Q | -1,487,100 | -3.74 | 7,323,090 | 5,745,977 | |
| 2025-06-30 | 10-Q | -1,761,858 | -0.85 | 5,306,002 | 3,423,513 | |
| 2025-03-31 | 10-K | -13,388,089 | -8.58 | 7,359,534 | 5,123,530 | |
| 2024-12-31 | 10-Q | -1,754,783 | -10.05 | 6,525,359 | 4,334,166 | |
| 2024-09-30 | 10-Q | -2,806,973 | -16.11 | 8,847,330 | 6,019,108 | |
| 2024-06-30 | 10-Q | -2,571,440 | -2.76 | 11,415,417 | 8,712,616 | |
| 2024-03-31 | 10-K | 0 | -12,208,174 | -38.87 | 8,245,982 | 5,766,332 |
| 2023-12-31 | 10-Q | -3,466,121 | -1.37 | 10,436,728 | 7,611,257 | |
| 2023-09-30 | 10-Q | -3,034,456 | -1.22 | 12,828,329 | 10,319,344 | |
| 2023-06-30 | 10-Q | -3,282,179 | -1.35 | 15,800,589 | 13,108,897 | |
| 2023-03-31 | 10-K | 574,245 | -12,029,786 | -5.86 | 17,508,940 | 15,064,210 |
| 2022-12-31 | 10-Q | 0 | -2,849,753 | -1.24 | 20,724,499 | 17,279,199 |
| 2022-09-30 | 10-Q | 0 | -3,807,430 | -1.84 | 23,047,199 | 19,868,224 |
| 2022-06-30 | 10-Q | 0 | -2,905,668 | -0.19 | 17,132,218 | 14,920,198 |
| 2022-03-31 | 10-K | 294,165 | -10,416,091 | -0.71 | 19,417,954 | 16,991,400 |
| 2021-12-31 | 10-Q | 17,117 | -2,525,732 | -0.16 | 21,916,266 | 20,700,441 |
| 2021-09-30 | 10-Q | 131,966 | -2,007,979 | -0.13 | 23,874,185 | 23,038,710 |
| 2021-06-30 | 10-Q | 131,966 | -2,097,303 | -0.16 | 25,867,011 | 24,873,761 |
| 2021-03-31 | 10-K | 659,104 | -7,886,709 | 10,668,916 | 9,430,604 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 2,047 | 0 | 2,047 | 5,670 | Neu | +100,0% | |
| CITIGROUP INC | 33 | 0 | 33 | 91 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 14 | 0 | 14 | 39 | Neu | +100,0% | |
| BlackRock, Inc. | 10 | 0 | 10 | 28 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 6 | 0 | 6 | 17 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 3 | 0 | 3 | 7 | Neu | +100,0% | |
| DANSKE BANK A/S | 1 | 0 | 1 | 3 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| MORGAN STANLEY | 2,047 | 5,670 | 96.84 |
| CITIGROUP INC | 33 | 91 | 1.55 |
| GROUP ONE TRADING LLC | 14 | 39 | 0.67 |
| BlackRock, Inc. | 10 | 28 | 0.48 |
| BANK OF AMERICA CORP /DE/ | 6 | 17 | 0.29 |
| WELLS FARGO & COMPANY/MN | 3 | 7 | 0.12 |
| DANSKE BANK A/S | 1 | 3 | 0.05 |